General

Cell Line

hPSCreg name CDIi019-A-1
Cite as:
CDIi019-A-1
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines
CDIi019-A
(PPMI_52062, FCDI_11299)
Donor diseases:
Parkinson Disease
LCSBi012-A-1
(RHOT1_T610A_clone62.19.37_IsogenicControl)
Donor diseases:
Parkinson Disease
LCSBi008-A-1
(delP GC13, DJ-1-delP GC13)
Donor diseases:
Parkinson Disease
CBIGi039-A-1
(IPSC0051, LRRK2 R1441H(CBIGi039-A) correction)
Donor's gene variants:
LRRK2, LRRK2
Donor diseases:
Parkinson Disease
CBIGi041-A-1
(IPSC0054, GBA L444P (CBIGi041-A) correction)
Donor's gene variants:
GBA, GBA
Donor diseases:
Parkinson Disease
CBIGi042-A-1
(GBA E326K (CBIGi042-A) correction, IPSC0056)
Donor's gene variants:
GBA, GBA
Donor diseases:
Parkinson Disease
CBIGi044-A-1
(IPSC0059, LRRK2 N551K (CBIGi044-A) correction)
Donor's gene variants:
LRRK2, LRRK2
Donor diseases:
Parkinson Disease
CBIGi044-A-2
(IPSC0060, LRRK2 R1398H (CBIGi044-A) correction)
Donor's gene variants:
LRRK2, LRRK2
Donor diseases:
Parkinson Disease
SUSMi005-A-1
(SNCA3X 0KO C1, SNCA3X 0KO C2)
Donor diseases:
obsolete_Parkinson's disease
SUSMi005-A-2
(SNCA3X 1KO C2, SNCA3X 1KO C1)
Donor diseases:
obsolete_Parkinson's disease
SUSMi005-A-3
(SNCA3X 2KO C1, SNCA3X 2KO C2)
Donor diseases:
obsolete_Parkinson's disease
SUSMi005-A-4
(SNCA3X 3KO C1, SNCA3X 3KO C2)
Donor diseases:
obsolete_Parkinson's disease
SUSMi005-A-5
(SNCA3X 4KO C1, SNCA3X 4KO C2)
Donor diseases:
obsolete_Parkinson's disease
LCSBi011-A-1
(RHOT1_T351A_clone25.2_IsogenicControl)
Donor diseases:
Parkinson Disease
EDi001-A-1
(AST22-C, AST23-C)
Donor's gene variants:
SNCA, SNCA
Donor diseases:
Parkinson disease
EDi001-A-2
(AST23-1KO-3, AST22-1KO-3, AST-23_SCAKO Clone 3, AST-22_SNCAKO Clone 3)
Donor's gene variants:
SNCA, SNCA, SNCA, SNCA
Donor diseases:
Parkinson disease
EDi001-A-3
(AST23_SNCAKO Clone 1, AST22-1KO-1, AST23-1KO-1, AST22_SNCAKO Clone 1)
Donor's gene variants:
SNCA, SNCA, SNCA, SNCA
Donor diseases:
Parkinson disease
EDi001-A-4
(AST22-2KO-6, AST23_SNCAKO Clone 6, AST22_SNCAKO Clone 6, AST23-2KO-6)
Donor's gene variants:
SNCA, SNCA, SNCA, SNCA
Donor diseases:
Parkinson disease
MPIi003-A-1
(IM2GC, L2-2GC)
Donor diseases:
obsolete_Parkinson's disease
EDi001-B-1
(AST18-7A)
Donor's gene variants:
SNCA
Donor diseases:
Parkinson disease
EDi001-B-2
(AST18-7B)
Donor's gene variants:
SNCA
Donor diseases:
Parkinson disease
EDi001-B-3
(AST18-5D)
Donor's gene variants:
SNCA
Donor diseases:
Parkinson disease
EDi001-B-4
(AST18-6A)
Donor's gene variants:
SNCA
Donor diseases:
Parkinson disease
EDi001-A-5
(AST23-2KO-II8B)
Donor's gene variants:
SNCA
Donor diseases:
Parkinson disease
CBIGi006-A-1
(IPSC0007, LRRK2 G2019S-correction)
Donor diseases:
Parkinson Disease
CBIGi007-A-1
(IPSC0009, TMEM175 Q65Q homozygous correction)
Donor's gene variants:
TMEM175, TMEM175
Donor diseases:
Parkinson Disease
CBIGi007-A-2
(IPSC0010, TMEM175 P65P homozygous disease)
Donor's gene variants:
TMEM175, TMEM175
Donor diseases:
Parkinson Disease
CBIGi009-A-1
(IPSC0013, TMEM175 M393T homozygous correction)
Donor's gene variants:
TMEM175, TMEM175
Donor diseases:
Parkinson Disease
CBIGi013-A-1
(LRRK2 M1646T correction, IPSC0018)
Donor's gene variants:
LRRK2, LRRK2
Donor diseases:
Parkinson Disease
CBIGi027-A-1
(IPSC0039, LRRK2 G2385R (CBIGi027) correction)
Donor's gene variants:
LRRK2, LRRK2
Donor diseases:
Parkinson Disease
STBCi004-B-1
(SFC832-03-06 LRRK2WT/WT C47)
Donor's gene variants:
LRRK2
Donor diseases:
Parkinson disease
LCSBi009-A-1
(RHOT1_R272Q_clone18_IsogenicControl)
Donor diseases:
Parkinson Disease
LCSBi010-A-1
(RHOT1_R450C_clone6_IsogenicControl)
Donor diseases:
Parkinson Disease
LCSBi010-A-2
(RHOT1_R450C_clone10_IsogenicControl)
Donor diseases:
Parkinson Disease
ICGi043-A-1
(LR-21-cytoGRX-3c)
Donor's gene variants:
LRRK2
Donor diseases:
Parkinson Disease
ICGi015-B-1
(m6.7pCyto-17)
Donor diseases:
Parkinson Disease
ICGi015-B-2
(m6.7pCyto-21)
Donor diseases:
Parkinson Disease
ICGi015-B-3
(m6.7pCyto-24)
Donor diseases:
Parkinson Disease
ICGi034-A-1
(PD30-XBP-RFP-6, PD30-4-7-XBP-RFP-6)
Donor diseases:
obsolete_Parkinson's disease
ICGi034-A-2
(PD30-4-7-XBP-RFP-51, PD30-XBP-RFP-51)
Donor diseases:
obsolete_Parkinson's disease
UMCGi012-A
(UMCG-PD-iPSC-T369M)
Donor diseases:
Parkinson Disease
UMCGi013-A
(UMCG-PD-iPSC-E326K)
Donor diseases:
Parkinson Disease
UMCGi014-A
(UMCG-PD-iPSC-nonGBA1/A)
Donor diseases:
Parkinson Disease
UMCGi015-A
(UMCG-PD-iPSC-nonGBA1/B)
Donor diseases:
Parkinson Disease
LCSBi008-A
(delP, DJ-1-delP)
Donor diseases:
Parkinson Disease
LCSBi001-A
(VPS35 1_2)
Donor diseases:
obsolete_Parkinson's disease
Last update 19th April 2024
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator FUJIFILM Cellular Dynamics, Inc. (CDI)
Owner The Michael J. Fox Foundation (MJFF)
Distributors

External Databases

BioSamples SAMEA115496881

General Information

* Is the cell line readily obtainable for third parties?
Yes
Research use: allowed
Clinical use: not allowed
Commercial use: not allowed
Subclone of

Donor Information

General Donor Information

Sex male

Phenotype and Disease related information (Donor)

Diseases A disease was diagnosed.
Parkinson's Disease/ LRRK2 G2019S
Synonyms
  • Parkinson Disease
  • Parkinson's disease
  • Parkinson's Disease

External Databases (Donor)

BioSamples SAMEA115473773

Ethics

Also have a look at the ethics information for the parental line CDIi019-A .
Is there an MTA available for the cell line? No
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used?

hIPSC Derivation

General

The source cell information can be found in the parental cell line CDIi019-A.

Reprogramming method

Vector free reprogramming

Other

Derived under xeno-free conditions
Unknown
Derived under GMP?
Unknown
Available as clinical grade?
Unknown

Culture Conditions

Characterisation

No characterisation data could be found for this subclone. Please open parental cell line CDIi019-A .

Genotyping

Karyotyping (Cell Line)

Other Genotyping (Cell Line)

Genetic Modification

Genetic modifications not related to a disease
Transgene expression
Engineered using nuclease-mediated methodologies to exhibit neomycin resistance under the control of a neuronal-specific promotor. Puromycin resistance was also included in the targeting vector to allow selection of the iPS cell line.